12 years of #NephJC. Countless papers discussed, ideas challenged, and friendships made.
🩵No paywalls. No pharma funding, just a community that believes in free, independent nephrology education.
🌟We need your help to keep it going. Please donate

12 years of #NephJC. Countless papers discussed, ideas challenged, and friendships made.
🩵No paywalls. No pharma funding, just a community that believes in free, independent nephrology education.
🌟We need your help to keep it going. Please donate
Can an oral small molecule provide renal and cardiovascular benefits just like the injectable GLP1 meds? The answer is probably so! New blog post today about Achieve 4 and it's CV trial that was presented at EASD. They also looked at it's renal benefits. So shout-out to #NephJC as well.
Select RCTs, informing current management strategies for patients with SA-AKI
#Nephpearls #AKIinICU #NephJC #NephSky
Can tolvaptan keep up with 3% saline?
This within-subject study in healthy volunteers delivered a surprising answer - and a few eyebrow-raising physiology twist. Dive in #NephJC
✍️ by @drsaivani.bsky.social
8/10 ⚠️ #NephJC Consensus
💡Underpowered (94/114 target, ~75% power), open-label, 2 center trial, wide margin (CI compatible w/ ~14 extra relapses/100 pts short-course), and FSGS trended toward favoring the longer taper underpowered subgroup
💡Hypothesis-generating only
7/10
Question 2
#NephJC #NephTwitter
Q: Can MCD & FSGS receive similar steroid taper regimens?
A: Probably not! We need a more adequately powered trial to answer this, especially with FSGS which remains more treatment resistant & steroid resistance may be disease defining
6/10
Question 1
#NephJC #Nephsky or #NephTwitter
Q: Should we stop steroids quickly in all podocytopathies?
A: Probably not, but this gives us evidence that we should explore this further in larger trial, as less steroids has less AE exposure, but also without more relapses
📢 The New #NephJC VA just dropped in !!!
@kireports.bsky.social
It's a study from @PGINEPHRO and I am a co-author🤩
Thanks to Dr. Raja Ramachandran, Dr. Arun
After obtaining remission, 2 months is non inferior to standard 4 months steroid tapering in podocytopathy.
#Nephbluesky #Nephsky #NephEd
Steroids are useful (and have bad side effects) in patients with podocytopathies.
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
El Resumen Visual, gracias @dramiliflores.bsky.social
#NephSky #NephJC
¿Cuánto debe durar la reducción gradual de esteroides tras la remisión de una podocitopatía?
www.nephjc.com/news/startspanish
Hey #NephJC 👋
Checkout the VA by @divyaveerssneph.bsky.social
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start🟢 but hard to stop 🛑.
#NephSky
www.nephjc.com/news/starttrial
See our discussion from #NephJc with author
www.kidneymedicinejournal.org/article/S259... in @kidneymed.bsky.social
We're in a revolution not only with GLP-1 meds, but also drugs that are kidney protective. It appears we can add orforglipron an oral GLP-1 small molecule to the list of kidney protective in diabetes. This data will be presented in full at EASD in 10 days. This is an eye opening graph #NephJC
BEST Fluids #NephJC summary
📣Hey #NephSky
We just passed 5000 #NephJC Newsletter subscribers
Will you be 5001?
Also, we can now be found at LinkedIN.
So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well!
www.nephjc.com/news/nephjc-on-linkedin
⏳ Just a bit over one month until #KidneyWk
And yes... the legendary #NephJC party is happening again 🎉
🩵Join us, meet the crew, and meet people from across the world
👇Grab your ticket and come be part of the magic
www.nephjc.com/news/2026/9/...
You want a ticket to the hottest event of #KidneyWk?
www.nephjc.com/news/2026/9/...
Consider a donation to the fall #NephJC pledge drive